Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma.

Item

http://www.wikidata.org/entity/Q36614148

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@ast

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@en

type

Item

label

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@ast

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@en

prefLabel

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@ast

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@en

P1476

Phase II study of docetaxel an ...... metastatic gastric carcinoma.

@en

P2093

C G Kim

http://www.w3.org/2001/XMLSchema#string

H K Kim

http://www.w3.org/2001/XMLSchema#string

I J Choi

http://www.w3.org/2001/XMLSchema#string

J H Chun

http://www.w3.org/2001/XMLSchema#string

J H Lee

http://www.w3.org/2001/XMLSchema#string

J S Lee

http://www.w3.org/2001/XMLSchema#string

J-M Bae

http://www.w3.org/2001/XMLSchema#string

K W Ryu

http://www.w3.org/2001/XMLSchema#string

M S Yu

http://www.w3.org/2001/XMLSchema#string

S R Park

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cancer statistics, 2004

Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

Irinotecan is active in chemonaive patients with metastatic gastric cancer: a phase II multicentric trial.

2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals.

Docetaxel (Taxotere) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group.

Randomized phase III trial of fluorouracil alone versus fluorouracil plus cisplatin versus uracil and tegafur plus mitomycin in patients with unresectable, advanced gastric cancer: The Japan Clinical Oncology Group Study (JCOG9205).

Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer.

Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial.

CPT-11 and cisplatin in the treatment of advanced gastric cancer in Asians.

P2888

sj.bjc.6603133

P304

1402-1406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6603133

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7139060

http://www.w3.org/2001/XMLSchema#string

P698

16641896

http://www.w3.org/2001/XMLSchema#string

P932

2361264

http://www.w3.org/2001/XMLSchema#string